Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

COSCIENS Biopharma Inc T.AEZ


Primary Symbol: T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

Comment by prophetoffactzon Jul 05, 2024 7:45pm
87 Views
Post# 36120718

RE:RE:RE:A Big Thank you to Proph

RE:RE:RE:A Big Thank you to Proph"gagnon is a micromanager... in all cases micromanagers will try to surround themselves with people who are inferior to them because other they will be threatened."

Gilles Gagnon has formed a mastermind alliance that brings together a diverse group of leading experts from various fields. The alliance includes:
  1. Dr. Bernhard Seifried: Co-inventor of PGX, a leading technology in the field of supercritical fluids. Seifried's expertise has been instrumental in scaling up PGX. Indistry leader Natex is also assisting with PGX scale-up.
  2. Dr. William Li: A renowned expert in bioactives and human health, Li is a New York Times bestseller and has published numerous articles in prestigious scientific journals such as the New England Journal of Medicine.
  3. Dr. Martin Kolb and Dr. Kjetil Ask: This duo played a crucial role in bringing a leading inhaled IPF drug to advanced trials, securing significant funding of approximately C$238 million.
  4. Dr. Todd Hoare: Recognized as a top expert in his field, Hoare's contributions to the alliance are substantial.
  5. Dr. Jean-Claude Tardif: A world leader in the study of inflammation and heart disease, Tardif was involved in the development of the first and only FDA-approved treatment for these conditions.
  6. Ronnie Miller: Described as a pharmaceutical icon in Canada, Miller brings extensive experience from the world's largest biotech company.
This mastermind alliance, led by Gilles Gagnon, leverages the collective expertise of these prominent figures to drive innovation and progress in their respective fields.


<< Previous
Bullboard Posts
Next >>